Ghrelin reduction after esophageal substitution and its correlation to postoperative body weight loss in esophageal cancer patients

Yuichiro Doki(Osaka International Cancer Institute), F Sasakuma(Osaka Medical Center for Cancer and Cardiovascular Diseases), Isao Miyashiro(Osaka International Cancer Institute), Osamu Ishikawa(Gunma University), Ko Takachi(Osaka Medical Center for Cancer and Cardiovascular Diseases), Hiroaki Ohigashi, Kenji Kangawa(National Cerebral and Cardiovascular Center), Yo Sasaki(SHOWA Medical University), Hiroshi Hosoda(National Cerebral and Cardiovascular Center), Hideo Nakajima(Osaka International Cancer Institute)
Surgery
June 1, 2006
10.1016/j.surg.2005.11.015
Cited by 61

Related Papers

Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
|Science|2004|1.1k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899
The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration
|Neuron|2017|641